BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7900080)

  • 1. Evaluation of recently described tests for detection of the lupus anticoagulant.
    Forastiero RR; Cerrato GS; Carreras LO
    Thromb Haemost; 1994 Nov; 72(5):728-33. PubMed ID: 7900080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant.
    Zanon E; Saracino MA; Simioni P; Scarano L; Girolami B; Girolami A
    Clin Lab Haematol; 1995 Sep; 17(3):231-5. PubMed ID: 8719896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la Thrombose.
    Goudemand J; Caron C; De Prost D; Derlon A; Borg JY; Sampol J; Sié P
    Thromb Haemost; 1997 Feb; 77(2):336-42. PubMed ID: 9157593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between a one-point dilute phospholipid APTT and the dilute Russell viper venom time for verification of lupus anticoagulants.
    Alving BM; Barr CF; Johansen LE; Tang DB
    Thromb Haemost; 1992 Jun; 67(6):672-8. PubMed ID: 1509408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of test methods for the lupus anticoagulant: international survey on lupus anticoagulants-I (ISLA-1).
    Exner T; Triplett DA; Taberner DA; Howard MA; Harris EN
    Thromb Haemost; 1990 Nov; 64(3):478-84. PubMed ID: 2128977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants].
    Magdelaine A; Verdy E
    Ann Biol Clin (Paris); 1996; 54(7):293-6. PubMed ID: 8952726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM; Marlar RA
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulants.
    Triplett DA; Stocker KF; Unger GA; Barna LK
    Thromb Haemost; 1993 Dec; 70(6):925-31. PubMed ID: 8165613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification.
    Triplett DA; Barna LK; Unger GA
    Thromb Haemost; 1993 Nov; 70(5):787-93. PubMed ID: 8128436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The laboratory diagnosis of lupus anticoagulants.
    Lazarchick J; Kizer J
    Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT; Triplett DA; Musgrave K; Orr C
    Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers.
    Lawrie AS; Mackie IJ; Purdy G; Machin SJ
    Thromb Haemost; 1999 May; 81(5):758-62. PubMed ID: 10365750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of phospholipid on the detection of lupus anticoagulants by the dilute Russell viper venom time.
    Brandt JT; Triplett DA
    Arch Pathol Lab Med; 1989 Dec; 113(12):1376-8. PubMed ID: 2511818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing strategies for diagnosing lupus anticoagulant: decision analysis.
    Segal JB; Lehmann HP; Petri M; Mueller L; Kickler TS
    Am J Hematol; 2002 Jul; 70(3):195-205. PubMed ID: 12111765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.